Long-term results of the fludarabine, cyclophosphamide, and rituximab regimen as initial therapy of chronic lymphocytic leukemia.

MLA

Tam, Constantine S., et al. “Long-Term Results of the Fludarabine, Cyclophosphamide, and Rituximab Regimen as Initial Therapy of Chronic Lymphocytic Leukemia.” Blood, vol. 112, no. 4, Aug. 2008, pp. 975–80. EBSCOhost, https://doi.org/10.1182/blood-2008-02-140582.

APA

Tam, C. S., O’Brien, S., Wierda, W., Kantarjian, H., Wen, S., Do, K.-A., Thomas, D. A., Cortes, J., Lerner, S., & Keating, M. J. (2008). Long-term results of the fludarabine, cyclophosphamide, and rituximab regimen as initial therapy of chronic lymphocytic leukemia. Blood, 112(4), 975–980. https://doi.org/10.1182/blood-2008-02-140582

Chicago

Tam, Constantine S, Susan O’Brien, William Wierda, Hagop Kantarjian, Sijin Wen, Kim-Anh Do, Deborah A Thomas, Jorge Cortes, Susan Lerner, and Michael J Keating. 2008. “Long-Term Results of the Fludarabine, Cyclophosphamide, and Rituximab Regimen as Initial Therapy of Chronic Lymphocytic Leukemia.” Blood 112 (4): 975–80. doi:10.1182/blood-2008-02-140582.